Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
Michael Hadley/LinkedIn
Dec 18, 2025, 15:23

Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals

Michael Hadley, System Director of Advanced Cardiac Imaging at Northwell Health, shared on LinkedIn:

”Well-timed ACC Statement just out in JACC Journals on reporting Quantitative Coronary Plaque Analysis (QCPA)

Key takeaways:

  • Use QCPA only when visual plaque is present to enhance risk assessment and guide initiation or intensification of preventive therapies
  • Required in reports (see figure): TPV, NCPV, CPV, qualitative statement about overall plaque, list of excluded segments, and comparison to any prior
  • To improve specificity, high-risk plaque is redefined as mild-moderate stenosis with both positive remodeling (>1.2x) and lipid-rich plaque (<70 HU)
  • Serial QCPA could be considered after 2-5+ years if it would change management, with plaque progression defined as ≥10-20mm3 of TPV or ≥5-10mm3 of NCPV
  • We need a shared validation dataset including IVUS/histology to evaluate the growing number or QCPA platforms

Bottom line: A strong first step toward standardized plaque reporting and building real trust in a tool built to personalize prevention.”

Read the full article here.

Article: Quantitative Coronary Plaque Analysis in Clinical Practice: 2025 ACC Scientific Statement

Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals

Stay updated on all scientific advances with Hemostasis Today.

ACC Coronary Plaque Health Hematology Hemostasis Hemostasis Today JACC Journals Medicine Michael Hadley QCPA thrombosis
NewsFeed